日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma.

通过创新的基于 cVLP 的疫苗靶向 PCSK9,增强了 cVLP-HER2 疫苗在 HER2 阳性乳腺癌临床前模型中的治疗活性

Scalambra Laura, Ruzzi Francesca, Pittino Olga Maria, Semprini Maria Sofia, Cappello Chiara, Angelicola Stefania, Palladini Arianna, Nanni Patrizia, Goksøyr Louise, Fougeroux Cyrielle, Penichet Manuel L, Sander Adam Frederik, Lollini Pier-Luigi

The C-terminal tail of α-synuclein protects against aggregate replication but is critical for oligomerization

α-突触核蛋白的C端尾部可防止聚集体复制,但对寡聚化至关重要。

Farzadfard, Azad; Pedersen, Jannik Nedergaard; Meisl, Georg; Somavarapu, Arun Kumar; Alam, Parvez; Goksøyr, Louise; Nielsen, Morten Agertoug; Sander, Adam Frederik; Knowles, Tuomas P J; Pedersen, Jan Skov; Otzen, Daniel Erik

Imiquimod Boosts Interferon Response, and Decreases ACE2 and Pro-Inflammatory Response of Human Bronchial Epithelium in Asthma.

咪喹莫特可增强干扰素反应,并降低哮喘患者支气管上皮细胞的 ACE2 和促炎反应

Nieto-Fontarigo Juan José, Tillgren Sofia, Cerps Samuel, Sverrild Asger, Hvidtfeldt Morten, Ramu Sangeetha, Menzel Mandy, Sander Adam Frederik, Porsbjerg Celeste, Uller Lena

A VAR2CSA:CSP conjugate capable of inducing dual specificity antibody responses

能够诱导双特异性抗体反应的 VAR2CSA:CSP 结合物

Matondo Sungwa, Thrane Susan, Janitzek Christoph Mikkel, Kavishe Reginald Adolph, Mwakalinga Steven Boniface, Theander Thor Grundtvig, Salanti Ali, Nielsen Morten Agertoug, Sander Adam Frederik